Related Experiment Video
Updated: Jul 30, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Outcomes After Left Main Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Complicated
Aref El Nasasra1, Mathias Hochadel2, Ralf Zahn3
1Department of Cardiology, Klinikum Ludwigshafen, Ludwigshafen, Germany; Department of Cardiology, Soroka University Medical Center, Be'er Sheva, Israel.
Insights
Percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) with cardiogenic shock (CS) shows high success. However, left main PCI in AMI with CS patients is linked to increased mortality.
Area of Science:
- Cardiology
- Interventional Cardiology
- Acute Myocardial Infarction Management
Background:
- Early revascularization with PCI improves outcomes in acute myocardial infarction (AMI) complicated by cardiogenic shock (CS).
- PCI strategies vary based on coronary artery disease complexity, including left main (LM), single-vessel, 2-vessel, and 3-vessel disease.
Purpose of the Study:
- To compare outcomes of PCI in patients with AMI and CS across different coronary artery disease extents.
- To identify predictors of mortality in this high-risk patient population.
Main Methods:
- Analysis of prospective registry data from 2,348 patients with AMI and CS treated with PCI between 2010-2015.
- Patients were categorized into 4 groups: LM, 1-vessel, 2-vessel, and 3-vessel disease.
- Comparison of patient characteristics, procedural success, and in-hospital complications, including mortality and bleeding rates.
Main Results:
- Procedural success (TIMI-3 flow) was high across all groups (80.8%-84.6%).
- In-hospital mortality was significantly higher in LM PCI (55.9%) and 3-vessel disease (46.5%) compared to single-vessel (27.9%) and 2-vessel (33.9%) disease.
- Higher age, poor post-PCI flow, 3-vessel disease, and LM PCI were independent predictors of mortality.
Conclusions:
- PCI for LM disease in AMI with CS occurs in ~12.5% of cases and, despite high procedural success, is associated with increased mortality.
- Risk stratification and tailored treatment strategies are crucial for improving outcomes in AMI with CS patients undergoing PCI.
Abstract:
Early revascularization therapy with percutaneous coronary intervention (PCI) has been shown to improve outcomes in patients with acute myocardial infarction (AMI) complicated by cardiogenic shock (CS). Data from consecutive patients with AMI and CS treated with PCI enrolled into the prospective Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte-PCI registry were centrally collected and analyzed. Patients were divided into 4 groups with PCI for left main (LM), 1-vessel, 2-vessel, and 3-vessel diseases. Patients' characteristics, procedural features, antithrombotic therapies, and in-hospital complications were compared between the 4 groups. Between 2010 and 2015 a total of 2,348 consecutive patients with AMI and CS were treated by PCI in 51 hospitals, 295 for LM (15 for protected, 280 for unprotected) and single-vessel (n = 491), 2-vessel (n = 524), and 3-vessel disease (n = 1,038). Thrombolysis in myocardial infarction 3 patency of the culprit lesion after PCI was 84.3%, 84.0%, 80.8%, and 84.6% in single-vessel, 2-vessel, 3-vessel disease, and LM PCI, respectively, whereas in-hospital mortality was 27.9%, 33.9%, 46.5%, and 55.9%. Bleeding rates were low (2.0%-2.3 %) and not different between groups. In a multivariate analysis a higher age, thrombolysis in myocardial infarction flow <3 after PCI, 3-vessel disease, and LM PCI were independent predictors of mortality. In conclusion, PCI of the LM is performed in about 12.5% of patients with AMI and CS and was associated with a high procedural success rate, whereas mortality is increased with LM PCI.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Cardiopulmonary Resuscitation IV: Pharmacological Management
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Cardiopulmonary Resuscitation I: Adult

